INmune Bio, Inc. to Present at the 32nd Annual ROTH Conference on March 17

search

newsroom latest news (container)

Recent News

Feb 12, 2025

INmune Bio Opens Phase II in High Dose Cohort of INKmune™ Trial in Prostate Cancer

Read More

Feb 10, 2025

INmune Bio Announces Plan to Submit FDA Biologics License Application (BLA) Seeking Approval of CORD...

Read More

Jan 28, 2025

INmune Bio Inc. Expands INKmune Trial in Prostate Cancer to Veterans

Read More

This website uses cookies to facilitate the use of the website, improve its performance and security, and personalize the proposed content.